Healthcare / Health Information ServicesTSXV
$0.01
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 21%
FCF escenarios
weak_data · normalized FCF $-115664.00 · quality 50.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$2M
P/E
N/A
•EV/EBITDA
N/A
•ROE
76.8%
↑Gross Margin
81.5%
↑Debt/Equity
-1.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
-20.5%
FCF CAGR
—
FCF margin
-167.4%
FCF / Net income
0.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $272158.0 · net income $-529488.0 · FCF $-455587.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $272158.00 | $272158.00 | $526676.00 | $876414.00 | $995814.00 | $682511.00 |
| Net Income | $-529488.00 | $-529488.00 | $-194576.00 | $-97326.00 | $-2455.00 | $283.00 |
| EBITDA | $-453374.00 | $-453374.00 | $-127659.00 | $-44216.00 | $50985.00 | $58648.00 |
| EPS | — | — | — | — | -0.00 | 0.00 |
| Gross Margin | 81.5% | 81.5% | 96.4% | 85.4% | 74.3% | 93.4% |
| Operating Margin | -204.7% | -204.7% | -49.6% | -23.5% | -7.4% | -31.4% |
| Net Margin | -194.6% | -194.6% | -36.9% | -11.1% | -0.2% | 0.0% |
| Balance Sheet | ||||||
| Debt/Equity | -1.00 | -1.00 | -1.02 | -0.97 | -0.85 | -1.03 |
| Current Ratio | 0.27 | 0.27 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-455587.00 | $-455587.00 | $-115664.00 | $-56091.00 | $44328.00 | $-123428.00 |
| Returns | ||||||
| ROE | 76.8% | 76.8% | 70.4% | 19.3% | 0.6% | -0.1% |
| Valuation | ||||||
| P/E | — | — | — | — | — | 15000.00 |
| EV/EBITDA | — | — | — | — | 94.40 | 81.92 |
| Growth & Yield | ||||||
| Revenue Growth | -48.3% | -48.3% | -39.9% | -12.0% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → n/d
Residual
+0.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.